GLS2 and breast cancer: Additionally, an ectopic expression of GLS2 in SUM159 mesenchymal breast cancer cells enhanced mitochondrial activity and Gln consumption; it also inhibited mammosphere formation, which is a component of cancer-stem-cell potential, although it did not affect the proliferation of these cells.